AKT1 and cancer: Compared to PI3K/Akt inhibitors with serious side effects, the combination therapy using novel agents that are nontoxic, efficacious such as traditional Chinese medicine, and conventional chemotherapeutic agent like DDP significantly increased sensitization of cancer cells and reduced the toxicity of drugs via systemic regulation of multiple targets including PI3K/Akt [33–37].